TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Pennsylvania Investigators

Peter O'Dwyer, MD

Abramson Cancer Center of The ...


Philadelphia, Pennsylvania - 19104 (215-662-2812)

Abramson Cancer Center at University ...


Philadelphia, Pennsylvania - 19104

University of Pennsylvania Abramson Cancer ...


Philadelphia, Pennsylvania - 19104 (215-662-7383)

Hospital of the University of ...


Philadelphia, Pennsylvania - 19104
  • CLINICAL TRIALS 5
  • CONDITIONS20
  • INTERVENTIONS11
  • SINCE2008
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

September 2010 - September 2012
PD 0332991 in Treating Patients With Refractory Solid Tumors

October 2009 - October 2011
Study of Gemcitabine Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

April 2009 - July 2011
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer

August 2009 - January 2011
Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors

November 2008 - July 2010
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Adenocarcinoma

Neoplasms

Neoplasm Metastasis

Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Melanoma

Neoplasms, Germ Cell and Embryonal

Rectal Neoplasms

Colorectal Neoplasms

Cholangiocarcinoma

Breast Neoplasms, Male

Biliary Tract Neoplasms

Germinoma

Seminoma

Teratoma

Testicular Neoplasms

Dermoid Cyst

Pharmacological Study

Bevacizumab

Oxaliplatin

Leucovorin

Hydroxychloroquine

5-Fluorouracil

Pd-0332991

Gemcitabine, Irinotecan, Panitumumab

Mgcd265+Erlotinib

Mgcd265+Docetaxel

Xl888

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo